Navigation Links
Procleix HIV-1/HCV Assay

ProductsProcleix HIV-1/HCV Assay
Company Gen-Probe
Item Procleix HIV-1/HCV Assay
Features 
  • Target capture, and a unique nucleic acid amplification technique called Transcription-Mediated Amplification (TMA)
  • The Procleix HIV-1/HCV Assay can simultaneously detect the presence of HIV-1 and HCV in blood donor samples
  • The combination HIV-1/HCV test system was developed and manufactured by Gen-Probe and is marketed worldwide as the Procleix System by Chiron Corporation
Description Donor Screening: The Procleix System has added a significant layer of a safety to the nation's blood supply. It utilizes innovative technologies developed by Gen-Probe including target capture, and a unique nucleic acid amplification technique called Transcription-Mediated Amplification (TMA). The Procleix HIV-1/HCV Assay can simultaneously detect the presence of HIV-1 and HCV in blood donor samples. The combination HIV-1/HCV test system was developed and manufactured by Gen-Probe and is marketed worldwide as the Procleix System by Chiron Corporation. In 2002, Gen-Probe received approval of its Biologics License Application (BLA) for the first FDA-approved nucleic acid test for HIV-1 and HCV in donated human blood. In the U.S. alone, the American Red Cross, the America's Blood Center's affiliates, the Association of Independent Blood Centers and the U.S. military screen over 80% of the blood units donated annually with the Procleix system. The assay is also currently approved and used in 15 foreign countries.
Info Gen-Probe
Customer Service: (800) 523-5001
Web site: http://www.gen-probe.com/

Related medicine products :

1. Uric Acid Enzymatic Assay
2. Lithium Enzymatic Assay Kit
3. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
4. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
5. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
6. VERSANT HIV RNA 3.0 Assay (bDNA)
7. Wampole PreVue B. Burgdorferi Antibody Detection Assay
8. VerifyNow Aspirin Assay
9. VerifyNow IIb/IIIa Assay
10. VerifyNow Clopidogrel Assay
11. VITROS® Anti-HBs Assay
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products:
(Date:5/4/2016)... ... ... Recognizing that lifestyle medicine is essential to health and healthcare, About.com ... MD, MPH, president of the American College of Lifestyle Medicine, as their first senior ... said Katz. “There is so much opportunity to add years to lives, and life ...
(Date:5/4/2016)... ... May 04, 2016 , ... The preeminent surgical aftercare ... Dickinson needed following breast cancer surgery. In March 2016, the 61-year-old model and reality ... breast cancer that occurs in the milk ducts, according to an interview with ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... support for knees, ankles, and elbows. Engineered with athletes in mind, OMNIFORCE ... manufacturing (opposed to ineffective circular knitting, common in the industry) produces premium ...
(Date:5/4/2016)... ... May 04, 2016 , ... With the stamp of ... the month of May as National Cancer Research Month. According to the American ... of cancer with predications of one in four Americans dying as a result. , ...
(Date:5/4/2016)... ... 04, 2016 , ... International Conference on Obesity and Chronic ... at Las Vegas. It aims to bring together academicians, scientists, dietitians, surgeons, physicians, ... across the globe; making the conference a perfect platform to share experience and ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... May 4, 2016 Global ... pages, profiling 09 key companies and supported with ... and in-depth study on the current state of ... of the industry including definitions, classifications, applications and ... is provided for the international market including development ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... Ariz. , May 3, 2016  As a ... twice contracted rheumatic fever, which damaged his heart. He ... But by June 2013, Shepherd,s heart was giving ... from death. On June 20, 2013, the ... Total Artificial Heart (TAH-t). Like a heart transplant, the ...
Breaking Medicine Technology: